2018 annual financial data
ImmuCell 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -3.4%.
Operating income was -1,447,000 USD and net income was -2,322,000 USD.
Operating cash flow was -373,404 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,986,000 USD
- Operating income
- -1,447,000 USD
- Net income
- -2,322,000 USD
- Operating cash flow
- -373,404 USD